Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model
Crossref DOI link: https://doi.org/10.1186/s12885-015-1064-9
Published Online: 2015-02-19
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brandes, Franziska
Schmidt, Katharina
Wagner, Christine
Redekopf, Julia
Schlitt, Hans Jürgen
Geissler, Edward Kenneth
Lang, Sven Arke
License valid from 2015-02-19
Article History
Received: 22 December 2014
Accepted: 30 January 2015
First Online: 19 February 2015